COMMENTARYDoes atrial fibrillation confer a hypercoagulable state?
References (16)
- et al.
Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation
J Am Coll Cardiol
(1993) - et al.
Hematologic correlates of spontaneous echo contrast in patients with atrial fibrillation and implications for thromboembolic risk
Am J Cardiol
(1994) - et al.
Increased cardiovascular clotting in patients with chronic atrial fibrillation
J Am Coll Cardiol
(1990) - et al.
Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease
Lancet
(1993) Risk factors for stroke and efficacy of antithrombotic treatment in atrial fibrillation: analysis of pooled data from randomized controlled trials
Arch Intern Med
(1994)Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk
Ann Intern Med
(1992)- et al.
Haemostatic and haemodynamic abnormalities are associated with left atrial spontaneous echo contrast without left atrial thrombus
Eur Heart J
(1995) - et al.
Clinical implications of left atrial spontaneous echo contrast in nonrheumatic atrial fibrillation
Am J Cardiol
(1992)
Cited by (219)
Current and potentially novel antithrombotic treatment in acute ischemic stroke
2024, Thrombosis ResearchAtrial Fibrillation in Heart Failure: Focus on Antithrombotic Management
2022, Cardiology ClinicsCitation Excerpt :The defective ANP synthesis in HF increases the tendency for AF.36,37 Both AF and HF have been independently shown to demonstrate Virchow’s triad: hypercoagulability (activation of platelet and clotting factors), endothelial dysfunction (dilatation and fibrosis of atria), and abnormal blood flow (abnormal atrial contraction/or lack thereof).38–43 AF is strongly associated with stroke and systemic embolism, and is influenced by associated risk factors.
Atrial Fibrillation in Heart Failure: Focus on Antithrombotic Management
2020, Heart Failure ClinicsCitation Excerpt :Congestive heart failure (CHF) has been shown to be an independent risk factor for stroke in AF, and the presence of the 2 conditions has been shown to incrementally increase stroke severity and all-cause mortality (Tables 2 and 3).45–50 Although stroke in HF is commonly associated with AF, HF, even in the absence of AF, also has a risk of thromboembolism and has been shown to increase platelet activation, with increased levels of procoagulant factors such as D-dimer and P-selectin.38–43 Many scoring systems have been developed to predict stroke risk in AF.